Immunocore Holdings plc·4

Feb 19, 4:19 PM ET

GOLL JOHN 4

4 · Immunocore Holdings plc · Filed Feb 19, 2025

Insider Transaction Report

Form 4
Period: 2025-02-17
GOLL JOHN
SVP, FINANCE & CAO
Transactions
  • Award

    Employee Share Option (Right to Buy)

    2025-02-17+14,80214,802 total
    Exercise: $29.60Exp: 2035-02-16Ordinary Shares (14,802 underlying)
  • Award

    Restricted Share Units

    2025-02-17+5,4055,405 total
    Ordinary Shares (5,405 underlying)
Footnotes (3)
  • [F1]25% of the shares subject to the option award shall vest on February 17, 2026, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.
  • [F2]Each restricted share unit ("RSU") represents a contingent right to receive one ordinary share.
  • [F3]The RSUs vest in four equal annual installments beginning February 17, 2026, subject to the Reporting Person's continuous service through each such vesting date.

Documents

1 file
  • 4
    form4-02192025_090208.xmlPrimary